The incidence of acute pancreatitis with GLP-1 receptor agonist therapy in individuals with a known history of pancreatitis

Authors: Lomeli, Laura D, Kodali, Alimitha M, Tsushima, Yumiko, Mehta, Adi E, Pantalone, Kevin M

Source: In Diabetes Research and Clinical Practice September 2024 215

American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis

Authors: Jellinger, Paul S., Smith, Donald A., Mehta, Adi E., Ganda, Om, Handelsman, Yehuda, Rodbard, Helena W., Shepherd, Mark D., Seibel, John A.

Source: In Endocrine Practice March-April 2012 18 Supplement 1:1-78

This result is not displayed to guests.
Login for full access.

Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial.

Authors: Hollander PA, Blonde L, Rowe R, Mehta AE, Milburn JL, Hershon KS, Chiasson J, Levin SR, Exubera Phase III Study Group, Hollander, Priscilla A, Blonde, Lawrence, Rowe, Richard, Mehta, Adi E, Milburn, Joseph L, Hershon, Kenneth S, Chiasson, Jean-Louis, Levin, Seymour R

Source: Diabetes Care; Oct2004, Vol. 27 Issue 10, p2356-2362, 7p

Efficacy and Safety of Inhaled Insulin (Exubera)Compared With Subcutaneous Insulin Therapy in PatientsWith Type 2 Diabetes.

Authors: Hollander, Priscilla A., Blonde, Lawrence, Rowe, Richard, Mehta, Adi E., Milburn, Joseph L., Hershon, Kenneth S., Chiasson, Jean-Louis, Levin, Seymour R.

Source: Diabetes Care; Oct2004, Vol. 27 Issue 10, p2356-2362, 7p, 2 Charts, 1 Graph

Subject Terms: INSULIN therapy, HYPOGLYCEMIC agents, INJECTIONS, HYPOGLYCEMIA, DRUG administration, TREATMENT of diabetes

DEVELOPMENT OF DIABETES MELLITUS SEVERAL YEARS AFTER MANIFESTATION OF DIABETIC NEPHROPATHY: CASE REPORT AND REVIEW OF LITERATURE

Authors: Siraj, Elias S., Myles, Jonathan, Nurko, Saul, Mehta, Adi E., FRCP, FACE, Reddy, S. Sethu K., FRCPC, FACP, FACE

Source: Endocrine Practice; August 2003, Vol. 9 Issue: 4 p301-306, 6p

Novel Use of GLP-1 Receptor Agonist Therapy in HNF4A-MODY.

Authors: Broome, David T., Tekin, Zehra, Pantalone, Kevin M., Mehta, Adi E.

Source: Diabetes Care; Jun2020, Vol. 43 Issue 6, pe65-e65, 1p

Subject Terms: GLUCAGON-like peptide-1 agonists, GLUCAGON-like peptide 1, CYCLIC-AMP-dependent protein kinase

Noninvasive diagnosis of resistant ovary syndrome by ultrasonography*†*Supported by the Manitoba Medical Services Foundation, Winnipeg, Manitoba, Canada.†Presented in part at the annual meeting of the Canadian Fertility and Andrology Society, Ville D’Estérel, Québec, Canada, October 3 to 6, 1990.

Authors: Mehta, Adi E., Matwijiw, Igor, Lyons, Edward A., Faiman, Charles

Source: Fertility and Sterility; January 1992, Vol. 57 Issue: 1 p56-61, 6p

Failure to Interrupt Established Pregnancy in Humans by d-Tryptophan-6-Luteinizing Hormone-Releasing Hormone

Authors: Tolis, George, Comaru-Schally, Anna Maria, Mehta, Adi E., Schally, Andrew V.

Source: Fertility and Sterility; August 1981, Vol. 36 Issue: 2 p241-242, 2p

Primary radiotherapy of prolactinomas: Eight- to 15-year follow-up

Authors: Mehta, Adi E., Reyes, Francisco I., Faiman, Charles

Source: In The American Journal of Medicine 1987 83(1):49-58

Androgen Excess Disorders in Women

Authors: Mehta, Adi E

Source: In Trends in Endocrinology & Metabolism 1998 9(3):129-130